Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693138018 | Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693139014 | Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693141010 | Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Barrier preparation | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing calamine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has active ingredient | Dimeticone (substance) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has active ingredient | Zinc oxide | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has active ingredient | Calamine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has active ingredient | Pharmaceutical base or inactive agent | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing calamine and zinc oxide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing dimeticone and zinc oxide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing calamine in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing zinc in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Count of base of active ingredient | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 75 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Zinc oxide | false | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Zinc oxide | false | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Calamine (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Dimeticone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Dimeticone (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 15 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Calamine (substance) | false | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator value | 200 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | false | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing only calamine and dimeticone and zinc oxide in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Calamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Calamine (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR